Sree Chitra to become lead nodal centre in country for study on Parkinson’s disease

  • | Thursday | 23rd January, 2020

By Express News ServiceTHIRUVANANTHAPURAM: The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Thiruvananthapuram, has been selected as the lead nodal centre in the country for an Indo-German collaborative research proposal - Genetic Architecture of Parkinson’s Disease (PD). The project was pitched by Manu Sharma from the University of Tubingen, Germany, and Asha Kishore, movement disorders specialist and director of SCTIMST. This will be the first Genome-Wide Association Study (GWAS) on PD in India,” read an excerpt of the statement from the institute. Besides SCTIMST, AIIMS New Delhi, NIMHANS Bangalore and Nizams Institute of Medical Sciences, Hyderabad, will be nodal centres. Approximately half a million genetic markers will be assessed to identify the Indian PD population-specific risk variants.

By Express News Service THIRUVANANTHAPURAM: The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Thiruvananthapuram, has been selected as the lead nodal centre in the country for an Indo-German collaborative research proposal - Genetic Architecture of Parkinson’s Disease (PD). The project was pitched by Manu Sharma from the University of Tubingen, Germany, and Asha Kishore, movement disorders specialist and director of SCTIMST. For carrying out the project, the Michel J Fox Foundation, USA, has given a grant of USD 2.3 million to the Centre for Movement Disorders in SCTIMST and to the Centre for Genetic Epidemiology in University of Tubingen. “A consortium of movement disorder specialists, neurologists, and geneticists from 20 Indian centres are co-investigators in the multi-centre international study along with the team in Germany led by Manu Sharma. This will be the first Genome-Wide Association Study (GWAS) on PD in India,” read an excerpt of the statement from the institute. Besides SCTIMST, AIIMS New Delhi, NIMHANS Bangalore and Nizams Institute of Medical Sciences, Hyderabad, will be nodal centres. Other than that, there will be 16 sub-centres. “This research aims to identify genetic risk factors of PD in India through GWAS. Approximately half a million genetic markers will be assessed to identify the Indian PD population-specific risk variants. To meet the objectives, more than 10,000 PD patients and 10,000 healthy controls will be recruited from across India to define a pan-Indian PD map,” said SCTIMST.

If You Like This Story, Support NYOOOZ

NYOOOZ SUPPORTER

NYOOOZ FRIEND

Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.


Stay updated with all the Latest Thiruvananthapuram headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.

Related Articles